XML 31 R19.htm IDEA: XBRL DOCUMENT  v2.3.0.11
POSTRETIREMENT BENEFITS
12 Months Ended
May 31, 2011
Postemployment Benefits Disclosure Abstract  
Postemployment Benefits Disclosure Text Block

NOTE M – POSTRETIREMENT BENEFITS

 

We sponsor several, unfunded-health-care-benefit plans for certain of our retired employees as well as post-retirement life insurance for certain key employees. Eligibility for these benefits is based upon various requirements. The following table illustrates the effect on operations of these plans for the three years ended May 31, 2011:

 

  U.S. Plans  Non-U.S. Plans
               
(In thousands)  2011 2010 2009  2011 2010 2009
               
Service cost - Benefits earned during the period $ 5$ 3$ 3 $ 736$ 338$ 358
Interest cost on the accumulated obligation   439  569  576   925  664  688
Amortization of:              
Prior service cost   (86)  (28)  (27)       
Unrecognized losses   (191)  (137)  (96)   89  (139)  
               
Net Periodic Postretirement Expense $ 167$ 407$ 456 $ 1,750$ 863$ 1,046
               
               

The changes in benefit obligations of the plans at May 31, 2011 and 2010 were as follows:
  U.S. Plans  Non-U.S. Plans
         
(In thousands)  2011 2010 2011 2010
         
Accumulated postretirement benefit obligation at        
beginning of year$ 7,936$ 8,584$ 14,974$ 8,133
         
Service cost  5  3  709  338
         
Interest cost  439  569  891  664
         
Benefit payments  (633)  (568)  (317)  (323)
         
Plan amendments    (592)    
         
Medicare subsidy received  97  104    
         
Actuarial (gains) losses  1,259  (164)  (33)  5,856
         
Currency exchange rate changes      1,333  306
         
Accumulated and accrued postretirement benefit        
obligation at end of year$ 9,103$ 7,936$ 17,557$ 14,974
         
         
In determining the postretirement benefit amounts outlined above, measurement dates as of May 31 for each period were applied.

Amounts recognized in the Consolidated Balance Sheets for the years ended May 31, 2011 and 2010 are as follows: 
          
  U.S. Plans  Non-U.S. Plans 
          
(In thousands)  2011 2010 2011 2010 
          
          
          
Current liabilities$ (672)$ (578)$ (380)$ (315) 
          
Noncurrent liabilities  (8,431)  (7,358)  (17,177)  (14,659) 
          
Net Amount Recognized$ (9,103)$ (7,936)$ (17,557)$ (14,974) 
          
          

The following table presents the pretax net actuarial gain (loss) and prior service credits recognized in accumulated other
comprehensive income (loss) not affecting retained earnings:
           
   U.S. Plans  Non-U.S. Plans
(In thousands)  2011 2010  2011 2010
           
Net actuarial gain (loss) $ 778$ 2,227 $ (2,943)$ (2,824)
           
Prior service credits   689  776     
           
Total recognized in accumulated other comprehensive          
income not affecting retained earnings $ 1,467$ 3,003 $ (2,943)$ (2,824)
           

The following table includes the changes recognized in other comprehensive income:   
                  
        U.S. Plans  Non-U.S. Plans
                  
(In thousands)    2011  2010  2011  2010
Changes in plan assets and benefit obligations            
 recognized in other comprehensive income:            
  Prior service cost  $ - $ (592) $ - $ -
  Net loss (gain) arising during the year*   1,259   (164)   (33)   5,799
  Effect of exchange rates on amounts included in AOCI         241   (57)
Amounts recognized as a component of net periodic            
 benefit cost:              
  Amortization or curtailment recognition of prior service            
   credit (cost)   86   26      
  Amortization or settlement recognition of net gain (loss)   191   138   (89)   137
                  
  Total recognized in other comprehensive loss (income) $ 1,536 $ (592) $ 119 $ 5,879
                  
* Includes curtailment gains not recognized as a component of net periodic pension cost.

The following weighted-average assumptions were used to determine our year-end benefit obligations and net periodic postretirement
benefit costs under the plans:  
    U.S. Plans    Non-U.S. Plans
             
Year-End Benefit Obligations   2011 2010   2011 2010
             
Discount rate   4.75% 5.75%   5.75% 5.75%
Current healthcare cost trend rate   7.87% 8.04%   7.00% 7.40%
Ultimate healthcare cost trend rate   4.50% 4.50%   4.50% 4.50%
Year ultimate healthcare cost trend rate will be realized 2029 2029   2030 2030
             
             
             
  U.S. Plans  Non-U.S. Plans
             
Net Periodic Pension Cost 2011 2010 2009 2011 2010 2009
             
Discount rate 5.75% 6.90% 6.50% 5.75% 8.00% 6.50%
Healthcare cost trend rate 8.04% 8.60% 8.50% 7.40% 10.00% 6.50%
Ultimate healthcare cost trend rate 4.50% 4.50% 5.00% 4.50% 5.00% 4.50%
Year ultimate healthcare cost trend rate will            
be realized 2029 2029 2015 2030 2024 2012
             

Increasing or decreasing current healthcare cost trend rates by 1% would affect our accumulated postretirement benefit obligation and
net postretirement expense by the following amounts for the years ended May 31, 2011 and 2010:
           
   U.S. Plans  Non-U.S. Plans
(In thousands)  2011 2010  2011 2010
1% Increase in trend rate          
Accumulated Benefit Obligation $ 442$ 380 $ 3,938$ 3,231
Postretirement Cost   22  34   423  209
1% Decrease in trend rate          
Accumulated Benefit Obligation $ (394)$ (338) $ (3,039)$ (2,499)
Postretirement Cost   (19)  (30)   (320)  (161)
           

We expect to pay approximately $1.2 million in estimated postretirement benefits in each of the next five years. In the five years thereafter (2017-2021) we expect to pay a cumulative total of $7.8 million.

 

The Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the “Act”), was signed into law on December 8, 2003. The Act provides for prescription drug benefits under Medicare Part D and contains a subsidy to plan sponsors who provide “actuarially equivalent” prescription drug plans. Our actuary has determined that the prescription drug benefit provided by our postretirement plan is considered to be actuarially equivalent to the benefits provided under the Act for all years since inception.

 

We have included the impact of our portion of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 subsidy in the determination of accumulated postretirement benefit obligation for the U.S. nonpension postretirement benefit plan for the periods ended May 31, 2010. For the fiscal years ended May 31, 2011 and 2010, we received reimbursements from Medicare related to this law amounting to approximately $100,000 each year.